All posts
14550 total · page 182 of 291
Pharma responses to inflation, input cost pressures and currency volatility
Pharma adapts strategies to tackle rising costs and volatility.
Export destination diversification and reducing reliance on few major markets
Exploring new markets can boost export stability and growth.
Strategies for managing excipient and packaging cost increases
Navigate rising excipient and packaging costs with smart strategies.
Efforts around generating local clinical data in India
Building local clinical data is vital for India's healthcare future.
Quality failures and recalls in Indian pharma and lessons learned
Indian pharma faces critical quality issues and recalls.
The role of biosafety and biosecurity regulations in drug manufacturing
Biosafety regulations ensure safer drug production practices.
India’s regulatory harmonization with global standards such as ICH and WHO
India aligns its regulations with global health standards.
Trends in vaccine development and local manufacturing capacity
Local vaccine production is reshaping global health strategies.
Reforms allowing conditional approvals for breakthrough therapies
New reforms speed up access to innovative therapies.
Patient safety and pharmacovigilance developments in the Indian market
India enhances patient safety through innovative pharmacovigilance.
The role of small and medium enterprises in India’s pharma exports
SMEs drive innovation and growth in India's pharma exports.
Impacts of trade agreements on pharma inputs and finished drugs
Trade agreements shape the landscape of pharmaceutical access.
Demand shifts in tier-2 and tier-3 cities shaping pharma strategies
Pharma strategies evolve as demand rises in smaller cities.
India’s strategy on biosimilars and pricing comparisons with biologics
India is redefining biosimilars, balancing affordability and quality.
Impact of digital marketing regulations on pharma brand awareness
New regulations reshape how pharma brands connect online.
How pharma associations are influencing policy and regulatory decisions
Pharma associations shape critical health policies today.
Drug safety scandals in India and reforms to rebuild public trust
India faces urgent reforms to restore trust in drug safety.
The role of corporate social responsibility in pharma sector development
Corporate social responsibility drives innovation in pharma.
The rising threat of antimicrobial resistance and Indian R&D responses
India's fight against antimicrobial resistance grows urgent.
Transparency initiatives in pricing and adverse event reporting
Increasing transparency in pricing boosts trust and safety.
Role of automation and AI in pharma manufacturing efficiency
Automation and AI are transforming pharma manufacturing efficiency.
Intellectual property enforcement and challenges in Indian pharma
India's pharma sector faces key hurdles in IP enforcement.
Economic policy shifts such as tax and subsidies affecting pharma inputs
Tax changes and subsidies reshape pharmaceutical input costs.
Impact of state government pharma clusters on regional growth
State pharma clusters boost local economies and innovation.
Trends in foreign direct investment in Indian pharma and biotech
Foreign investment in India's pharma sector is booming rapidly.
Comparative performance of Indian pharma versus other emerging markets
Indian pharma shows robust growth amid global competition.
Regulatory changes around fixed dose combinations in India
India's new regulations reshape fixed dose combination markets.
Challenges in cold chain and distribution for vaccines and biologics
Ensuring vaccine integrity through reliable cold chain logistics.
Trends in personalized medicine and genomics in Indian pharma
Indian pharma embraces personalized medicine and genomics advances.
The future of nutraceuticals and functional foods in Indian pharma portfolios
Nutraceuticals are shaping the future of Indian pharma.
Patient access programs by pharma companies and their regulatory oversight
Navigating the complexities of pharma patient access programs.
Pharma digital transformation with blockchain and supply chain traceability
Blockchain enhances pharma supply chain transparency and security.
Expansion of Indian pharma into Latin American and African markets
India's pharma industry is tapping into new global markets.
How Indian companies are preparing for stricter global audits
Indian firms gear up for tougher global audit standards.
Role of blockchain in ensuring authenticity of exported pharma goods
Blockchain enhances trust in exported pharmaceutical products.
Government investment in biotechnology and life sciences clusters
Government funding boosts innovation in biotech sectors.
India’s opportunity in contract research and manufacturing services
India is poised to lead in contract research and manufacturing.
Impact of global climate policies on pharma manufacturing in India
Global climate policies are reshaping India's pharma landscape.
Digital twin and smart manufacturing applications in pharma plants
Explore how digital twins enhance efficiency in pharma manufacturing.
The role of pharmacoeconomics in drug pricing decisions
Pharmacoeconomics shapes fair drug pricing strategies.
How pharma is integrating sustainability goals with business strategies
Pharma is blending sustainability with strategic growth plans.
Evolving norms around ethical clinical trial recruitment in India
New guidelines reshape ethical recruitment in India's trials.
How Indian companies are navigating global patent cliffs
Indian firms are innovating to overcome global patent challenges.
The impact of AI regulation on pharma research and marketing in India
AI regulation is reshaping pharma research and marketing in India.
New opportunities in veterinary pharmaceuticals for Indian exporters
Indian exporters explore rising demand in veterinary medicines.
The role of precision oncology in India’s drug pipeline
Precision oncology is transforming India's approach to drug development.
The intersection of healthcare insurance expansion and pharma demand
Insurance expansion boosts pharma demand in unexpected ways.
How Indian companies are preparing for competition in gene therapy
Indian firms are innovating to lead in gene therapy advancements.
The growth of digital therapeutics alongside pharmaceuticals
Digital therapeutics are reshaping healthcare alongside drugs.
Trends in over-the-counter medicines and regulatory changes in India
India's OTC medicine landscape is evolving rapidly.